FIH-dependent asparaginyl hydroxylation of ankyrin repeat domain-containing proteins

Annals of the New York Academy of Sciences

Volumn 1177, Issue , 2009, Pages 9-18

  Cockman, Matthew E ^a   Webb, James D ^a   Ratcliffe, Peter J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Ankyrin repeat domain (ARD); Factor inhibiting HIF (FIH); Hypoxia; Posttranslational hydroxylation

Indexed keywords

ANKYRIN; HYPOXIA INDUCIBLE FACTOR;

CONFERENCE PAPER; HYDROXYLATION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE;

EID: 70350389957     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05042.x     Document Type: Conference Paper

References (29)

1. Kaelin,W.G.J. & P.J. Ratcliffe. 2008. Oxygen sensing by metazoans: the central role of theHIF hydroxylase pathway. Mol. Cell 30: 393-402.
2. Lisy, K. & D.J. Peet. 2008. Turn me on: regulating HIF transcriptional activity. Cell DeathDiffer. 15: 642-649.
3. Cockman, M.E. et al. 2006. Posttranslational hydroxylation of ankyrin repeats in IêB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH). Proc. Natl. Acad. Sci. USA 103: 14767-14772.
4. Cockman, M.E. et al. 2008. Proteomic-based identifi- cation of novel factor inhibiting HIF (FIH) substrates indicates widespread hydroxylation of ankyrin repeat domain-containing proteins. Mol. Cell. Proteomics 8: 535-546.
5. Coleman, M.L. et al. 2007. Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor. J. Biol. Chem. 282: 24027-24038.
6. Webb, J.D. et al. 2009. MYPT1, the targeting subunit of smooth muscle myosin phosphatase, is a substrate for the asparaginyl hydroxylase factor inhibiting hypoxia inducible factor (FIH). Biochem. J. 420: 327-333.
7. Li, J., A. Mahajan & M.D. Tsai. 2006. Ankyrin repeat: a unique motif mediating protein-protein interactions. Biochemistry 45: 15168-15178.
8. Wilkins, S.E. et al. 2009. Differences in hydroxylation and binding of Notch and HIF-1α demonstrate substrate selectivity for factor inhibiting HIF-1 (FIH-1). Int. J. Biochem. Cell Biol. 41: 1563-1571.
9. Zheng, X. et al. 2008. Interaction with factor inhibiting HIF-1 defines an additional mode of crosscoupling between the Notch and hypoxia signaling pathways. Proc. Natl. Acad. Sci. USA 105: 3368-3373.
10. Koivunen, P. et al. 2003. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl-4- hydroxylases. J. Biol. Chem. 279: 9899-9904.
11. Elkins, J.M. et al. 2003. Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1α. J. Biol. Chem. 278: 1802-1806.
12. Dames, S.A. et al. 2002. Structural basis for hif- 1a/CBP recognition in the cellular hypoxic response. Proc. Natl. Acad. Sci. USA 99: 5271-5276.
13. Freedman, S.J. et al. 2002. Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α. Proc. Natl. Acad. Sci. USA 99: 5367-5372.
14. Kelly, L. et al. 2009. Asparagine beta-hydroxylation stabilizes the ankyrin repeat domain fold. Mol. Biosyst. 5: 52-58.
15. Kloss, E., N. Courtemanche & D. Barrick. 2008. Repeat-protein folding: new insights into origins of cooperativity, stability, and topology. Arch. Biochem. Biophys. 469: 83-99.
16. Ferguson, J.E., 3rd et al. 2007. ASB4 is a hydroxylation substrate of FIH and promotes vascular differentiation via an oxygen-dependent mechanism. Mol. Cell. Biol. 27: 6407-6419.
17. Myllyharju, J. & K.I. Kivirikko. 2004. Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet. 20: 33-43.
18. Truhlar, S.M. et al. 2008. Pre-folding IêBα alters control of NF-êB signaling. J. Mol. Biol. 380: 67-82.
19. Shin, D.H. et al. 2009. Inhibitor of nuclear factor-κBα derepresses hypoxia-inducible factor-1 during moderate hypoxia by sequestering factor inhibiting hypoxia-inducible factor from hypoxia-inducible factor 1α. FEBS J. e-pub: 16/05/09.
20. Galletti, P. et al. 2007. Accumulation of altered aspartyl residues in erythrocyte proteins from patients with Down's syndrome. FEBS J. 274: 5263-5277.
21. Weintraub, S.J. & B.E. Deverman. 2007. Chronoregulation by asparagine deamidation. Sci. STKE 2007: re7.
22. Kim, E. et al. 1997. Deficiency of a protein-repair enzyme results in the accumulation of altered proteins, retardation of growth, and fatal seizures inmice. Proc. Natl. Acad. Sci. USA 94: 6132-6137.
23. Lancaster, D.E.,M.A.McDonough & C.J. Schofield. 2004. Factor inhibiting hypoxia-inducible factor (FIH) and other asparaginyl hydroxylases. Biochem. Soc. Trans. 32: 943-945.
24. Cai,X. & Y. Zhang. 2006. Molecular evolution of the ankyrin gene family. Mol. Biol. Evol. 23: 550-558.
25. Barrick, D., D.U. Ferreiro & E.A. Komives. 2008. Folding landscapes of ankyrin repeat proteins: experiments meet theory. Curr. Opin. Struct. Biol. 18: 27-34.
26. Mosavi, L.K. et al. 2004. The ankyrin repeat as molecular architecture for protein recognition. Protein Sci. 13: 1435-1448.
27. Linke, S., R.J. Hampton-Smith & D.J. Peet. 2007. Characterization of ankyrin repeat-containing proteins as substrates of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible transcription factor. Meth. Enzymol. 435: 61-85.
28. Jacobs, M.D. & S.C. Harrison. 1998. Structure of an IκBα/NF-κB complex. Cell 95: 749-758.
29. Mosavi, L.K., D.L. Minor, Jr. & Z.-y. Peng. 2002. Consensus-derived structural determinants of the ankyrin repeat motif. Proc. Natl. Acad. Sci. USA 99: 16029-16034.